Fig. 2From: All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetesSurvival probability in the insulin with DPP-4 inhibitors and insulin without DPP-4 inhibitors group, obtained through Kaplan–Meier analysisBack to article page